製品: Smad9 Antibody
カタログ: AF5114
タンパク質の説明: Rabbit polyclonal antibody to Smad9
アプリケーション: WB IHC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Sheep, Chicken
分子量: 52 kDa; 52kD(Calculated).
ユニプロット: O15198
RRID: AB_2837600

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Sheep(100%), Chicken(86%)
クローナリティ:
Polyclonal
特異性:
Smad9 Antibody detects endogenous levels of total Smad9.
RRID:
AB_2837600
引用形式: Affinity Biosciences Cat# AF5114, RRID:AB_2837600.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

MAD homolog 9; Madh6; Mothers against decapentaplegic; Mothers against decapentaplegic homolog 9; Mothers against DPP homolog 9; SMAD 9; SMAD family member 9; SMAD, mothers against DPP homolog 9 (Drosophila); SMAD8A; SMAD8B; Smad9; SMAD9_HUMAN;

免疫原

免疫原:

A synthesized peptide derived from human Smad9, corresponding to a region within the internal amino acids.

Uniprot:
遺伝子(ID):
発現特異性:
O15198 SMAD9_HUMAN:

Expressed in heart, brain, placenta, lung, skeletal muscle, prostate, testis, ovary and small intestine. Also expressed in fetal brain, lung and kidney.

タンパク質の説明:
SMAD9 is a member of the MAD-related family of molecules. MAD-related proteins are a recently identified family of intracellular proteins that are thought to be essential components in the signaling pathways of the serine/threonine kinase receptors of the transforming growth factor beta superfamily.
タンパク質配列:
MHSTTPISSLFSFTSPAVKRLLGWKQGDEEEKWAEKAVDSLVKKLKKKKGAMDELERALSCPGQPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSKQKEVCINPYHYRRVETPVLPPVLVPRHSEYNPQLSLLAKFRSASLHSEPLMPHNATYPDSFQQPPCSALPPSPSHAFSQSPCTASYPHSPGSPSEPESPYQHSVDTPPLPYHATEASETQSGQPVDATADRHVVLSIPNGDFRPVCYEEPQHWCSVAYYELNNRVGETFQASSRSVLIDGFTDPSNNRNRFCLGLLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECVSDSSIFVQSRNCNYQHGFHPATVCKIPSGCSLKVFNNQLFAQLLAQSVHHGFEVVYELTKMCTIRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLTQMGSPHNPISSVS

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Sheep
100
Chicken
86
Horse
75
Dog
70
Rabbit
67
Pig
0
Bovine
0
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD9 is a receptor-regulated SMAD (R-SMAD).

PTMs:

Phosphorylated on serine by BMP (bone morphogenetic proteins) type 1 receptor kinase.

細胞の位置付け:

Cytoplasm. Nucleus.
Note: In the cytoplasm in the absence of ligand. Migration to the nucleus when complexed with SMAD4 (By similarity).

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed in heart, brain, placenta, lung, skeletal muscle, prostate, testis, ovary and small intestine. Also expressed in fetal brain, lung and kidney.

タンパク質ファミリー:

Belongs to the dwarfin/SMAD family.

研究領域

· Cellular Processes > Cellular community - eukaryotes > Signaling pathways regulating pluripotency of stem cells.   (View pathway)

· Environmental Information Processing > Signal transduction > TGF-beta signaling pathway.   (View pathway)

参考文献

1). Dual-function MgSrCeAl-LDH nanosheets enable both ROS clearance and enhanced angiogenesis for myocardial ischemia/reperfusion injury therapy. Journal of nanobiotechnology, 2025 (PubMed: 41139778) [IF=10.2]

Application: WB    Species: Rat    Sample:

Fig. 6 (a) Cluster analysis of total differentially expressed genes among the Control, OGD/R, and OGD/R + LDH groups, P 0.58, n = 3. (b) Volcano plot analysis of total differentially expressed genes between Control and OGD/R groups, P 0.58. (c) Volcano plot analysis of total differentially expressed genes between OGD/R and OGD/R + LDH groups, P 0.58, n = 3. (d) KEGG enrichment analysis of total differentially expressed genes between Control and OGD/R groups, P 1, n = 3. (e) KEGG enrichment analysis of total differentially expressed genes between OGD/R and OGD/R + LDH groups, P 1, n = 3. (f) Representative western blot bands of p-PI3K/PI3K/p-AKT/AKT/TGF-β/Smad9/β-actin after different treatments. (g) Quantification of p-PI3K/PI3K and p-AKT/AKT protein levels from (f), n = 4. (h) Co-staining images of p-PI3K9 (green) and α-actinin (red) after different treatments on Day 14, Scale bar = 20 μm, n = 5. (i, j) Heat map of expressed genes related to apoptosis signaling pathway and sprouting angiogenesis among the Control, OGD/R and OGD/R + LDH groups, P 0.58, n = 3. (k) GSEA analysis of sprouting angiogenesis between OGD/R and OGD/R + LDH groups, P 1.0, n = 3. (l) GSEA analysis of TGF-β signaling pathway between OGD/R and OGD/R + LDH groups, P 1.0, n = 3. (m) Heat map of expressed genes related to TGF-β signaling pathway among the Control, OGD/R and OGD/R + LDH groups, P 0.58, n = 3. (n) Quantification of TGF-β2 and Smad9 protein levels from (f), n = 4. Data are presented as mean values ± SEM

2). Dose-optimized HILT promotes peripheral nerve repair through BMP4-Smad9-mediated inhibition of neuroinflammation and oxidative stress. APL bioengineering, 2026 (PubMed: 41799557) [IF=6.6]

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.